St. Christopher’s Hospital for Children announced its third leadership change in less than two yearsA new $50 million investment fund will back Penn life sciences start-upsAlveus Therapeutics, a Philadelphia start-up treating obesity, debuted with $160M in fundingS&P downgraded ChristianaCare’s credit ratingTemple University Hospital is being investigated by CMS over its care of a homeless patient who diedDrug distribution giant Cencora is boosting its reach in medical specialtiesCalifornia biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia One year of inspections at Fox Chase Cancer Center: November 2024 - October 2025Drexel University signed a lease to consolidate medical college research in University CityChristianaCare and Virtua Health have ended merger talks
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
